Need professional-grade analysis? Visit stockanalysis.com
$520.36B
N/A
N/A
4.52%
BioNote Inc. (377740) trades on KO in KRW. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at KRW5130.00, down 2.84% from the previous close.
Over the past year, 377740 has traded between a low of KRW4485.00 and a high of KRW6230.00. The stock has gained 11.9% over this period. It is currently 17.7% below its 52-week high.
BioNote Inc. has a market capitalization of $520.36B and a dividend yield of 4.52%.
BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.
Side-by-side comparison against top Healthcare peers.